3-(6,8-Dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl)-propionic acid
CAS No.:
1000339-20-7
M. Wt:
220.22800
M. Fa:
C10H12N4O2
InChI Key:
DGACMJHUIBPMDO-UHFFFAOYSA-N
Names and Identifiers of 1000339-20-7
CAS Number |
1000339-20-7 |
|---|---|
MDL Number |
MFCD09881042 |
IUPAC Name |
3-(6,8-dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl)propanoic acid |
InChI |
InChI=1S/C10H12N4O2/c1-6-8(3-4-9(15)16)7(2)13-14-5-11-12-10(6)14/h5H,3-4H2,1-2H3,(H,15,16) |
InChIKey |
DGACMJHUIBPMDO-UHFFFAOYSA-N |
Canonical SMILES |
CC1=C(C(=NN2C1=NN=C2)C)CCC(=O)O |
UNSPSC Code |
12352100 |
Physical and chemical properties of 1000339-20-7
Exact Mass |
220.09600 |
|---|---|
H Bond Acceptors |
5 |
H Bond Donors |
1 |
LogP |
0.75830 |
Molecular Formula |
C10H12N4O2 |
Molecular Weight |
220.22800 |
PSA |
80.38000 |
Safety Information of 1000339-20-7
Applications of 1000339-20-7
The primary applications of 3-(6,8-Dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl)propanoic acid lie in:
- Pharmaceutical Research: Due to its potential biological activities.
- Chemical Biology: As a tool compound for studying specific biological pathways.
- Synthetic Chemistry: As an intermediate for developing new compounds with enhanced properties.
Biological Activity of 1000339-20-7
Research indicates that 3-(6,8-Dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl)propanoic acid exhibits notable biological activities. Preliminary studies suggest potential antiproliferative effects, making it a candidate for further investigation in cancer research. The unique structural features of this compound may contribute to its interaction with biological targets, although detailed mechanisms remain to be elucidated.
